
The big green blobs are retinal cells. Image: courtesy David Gamm, UW-Madison.
American scientists have taken a step towards a treatment for macular degeneration and other conditions which can cause loss of vision. For the first time, the scientists have shown that stem cells created from cells taken from the skin can be turned into cells from the retina – the light-sensing part of the eye.
The breakthrough raises the possibility that one day doctors will be able to carry out retinal transplants using pieces of retina grown from a patient’s own skin cells, which reduces the chance that any treatment might be rejected by the patient’s immune system. It also avoids the ethical concerns raised by the only available alternative, which involves using retina grown from embryonic stem cells.
Transplanting pieces of retina grown from stem cells is seen as a potential cure for conditions such as macular degeneration. People suffering from macular degeneration gradually lose the light-sensitive cells in their eyes. It is the most common cause of blindness and most often affects older people. In 2008, scientists and doctors demonstrated that transplanting patches of retinal cells into the eye of patients with macular degeneration could partly restore their vision. Unfortunately, such a treatment is still a long way away from becoming a standard medical procedure.
To grow the new retinal cells the scientists took skin cells and persuaded them to become stem cells by adding specific genes. These genes control the activity of other genes, and adding them to skin cells can “induce” the cells to become stem cells. The stem cells – known as “induced pluripotent stem cells”, or iPS – were then persuaded to turn into retinal cells of various kinds; something that has never been done before.
As the retinal cells develop in the laboratory in the same way as they do in a human embryo, the breakthrough will also make it much easier in future for scientists to investigate how our eyes and nervous systems develop.
